These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1533090)

  • 1. Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studies.
    Buster JE; Casson PR; Straughn AB; Dale D; Umstot ES; Chiamori N; Abraham GE
    Am J Obstet Gynecol; 1992 Apr; 166(4):1163-8; discussion 1168-70. PubMed ID: 1533090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of dehydroepiandrosterone to premenopausal women: effects of micronization and nonoral administration.
    Casson PR; Straughn AB; Umstot ES; Abraham GE; Carson SA; Buster JE
    Am J Obstet Gynecol; 1996 Feb; 174(2):649-53. PubMed ID: 8623801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women.
    Casson PR; Faquin LC; Stentz FB; Straughn AB; Andersen RN; Abraham GE; Buster JE
    Fertil Steril; 1995 May; 63(5):1027-31. PubMed ID: 7720912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term oral dehydroepiandrosterone treatment in postmenopausal women.
    Stanczyk FZ; Slater CC; Ramos DE; Azen C; Cherala G; Hakala C; Abraham G; Roy S
    Menopause; 2009; 16(2):272-8. PubMed ID: 19098687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.
    Arlt W; Haas J; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2170-6. PubMed ID: 10372727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
    Martel C; Labrie F; Archer DF; Ke Y; Gonthier R; Simard JN; Lavoie L; Vaillancourt M; Montesino M; Balser J; Moyneur É;
    J Steroid Biochem Mol Biol; 2016 May; 159():142-53. PubMed ID: 26972555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a 3-week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study.
    Caufriez A; Leproult R; L'Hermite-Balériaux M; Kerkhofs M; Copinschi G
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):716-24. PubMed ID: 23488643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic clearance rate of dehydroepiandrosterone sulfate, its metabolism to testosterone, and its intrafollicular metabolism to dehydroepiandrosterone, androstenedione, testosterone, and dihydrotestosterone in vivo.
    Haning RV; Flood CA; Hackett RJ; Loughlin JS; McClure N; Longcope C
    J Clin Endocrinol Metab; 1991 May; 72(5):1088-95. PubMed ID: 1827126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.
    Zimmerman Y; Foidart JM; Pintiaux A; Minon JM; Fauser BC; Cobey K; Coelingh Bennink HJ
    Contraception; 2015 Feb; 91(2):127-33. PubMed ID: 25604900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of dehydroepiandrosterone sulfate on serum steroid hormones in pregnant rabbits (author's transl)].
    Yamashita A; Hamada Y; Ishii H; Nose T
    Nihon Yakurigaku Zasshi; 1981 Feb; 77(2):187-94. PubMed ID: 6453760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian and circannual variations of FSH, LH, testosterone, dehydroepiandrosterone-sulfate (DHEA-S) and 17-hydroxy progesterone (17 OH-Prog) in elderly men and women.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Sackett-Lundeen L; Popescu M; Berg H; Petrescu E; Robu E
    Endocrinologie; 1985; 23(4):223-46. PubMed ID: 2935925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women.
    Lasco A; Frisina N; Morabito N; Gaudio A; Morini E; Trifiletti A; Basile G; Nicita-Mauro V; Cucinotta D
    Eur J Endocrinol; 2001 Oct; 145(4):457-61. PubMed ID: 11581005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic clearance rate (MCR) of dehydroepiandrosterone sulfate (DS), its metabolism to dehydroepiandrosterone, androstenedione, testosterone, and dihydrotestosterone, and the effect of increased plasma DS concentration on DS MCR in normal women.
    Haning RV; Chabot M; Flood CA; Hackett R; Longcope C
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1047-52. PubMed ID: 2529265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How effective is surgical adrenalectomy in lowering steroid hormone concentrations?
    Worgul TJ; Santen RJ; Samojlik E; Wells SA
    J Clin Endocrinol Metab; 1982 Jan; 54(1):22-6. PubMed ID: 6459336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.
    Forsblad-d'Elia H; Carlsten H; Labrie F; Konttinen YT; Ohlsson C
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2044-51. PubMed ID: 19318446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: a report of gender differences.
    Bloch M; Meiboom H; Zaig I; Schreiber S; Abramov L
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):910-8. PubMed ID: 23084789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen and SHBG serum concentrations in late post-menopause women.
    Skałba P; Wójtowicz M; Sikora J
    Med Sci Monit; 2003 Mar; 9(3):CR152-6. PubMed ID: 12640346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.